TREM2 and Alzheimer disease: The microglial innate immune receptor TREM2, the deficiency of which aggravates Aβ accumulation and neuron damage in AD (15), is essential for microglia-mediated synaptic refinement during the early stages of brain development (16), indicating abnormal microglia plays a key role in mediating synapse loss in AD (17).